The University of Chicago Header Logo

Connection

Richard Schilsky to Oligonucleotides, Antisense

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Oligonucleotides, Antisense.
Richard Schilsky
Connection Strength
0.065
Oligonucleotides, Antisense
  1. A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors. Ann Oncol. 2005 Jun; 16(6):958-65.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.